See more : The Goldman Sachs Group, Inc. (GS.NE) Income Statement Analysis – Financial Results
Complete financial analysis of Neptune Wellness Solutions Inc. (NEPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neptune Wellness Solutions Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Healthier Choices Management Corp. (HCMC) Income Statement Analysis – Financial Results
- Jiangsu Nata Opto-electronic Material Co., Ltd. (300346.SZ) Income Statement Analysis – Financial Results
- Universal Arts Limited (UNIVARTS.BO) Income Statement Analysis – Financial Results
- OpenWork Inc. (5139.T) Income Statement Analysis – Financial Results
- Apollo Tyres Limited (APOLLOTYRE.BO) Income Statement Analysis – Financial Results
Neptune Wellness Solutions Inc. (NEPT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.neptunewellness.com
About Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.62M | 61.01M | 44.49M | 29.58M | 24.44M | 27.65M | 43.22M | 22.63M | 15.07M | 19.50M | 25.95M | 19.25M | 17.06M | 12.05M | 10.32M | 7.60M | 6.28M | 4.01M | 1.66M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 74.45M | 71.58M | 80.07M | 31.42M | 16.83M | 21.32M | 31.40M | 18.06M | 23.09M | 16.97M | 15.63M | 9.12M | 14.21M | 10.61M | 8.91M | 5.88M | 5.90M | 3.62M | 2.71M | 2.71M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -21.84M | -10.58M | -35.58M | -1.84M | 7.61M | 6.32M | 11.82M | 4.57M | -8.02M | 2.52M | 10.31M | 10.13M | 2.85M | 1.43M | 1.41M | 1.72M | 382.33K | 398.16K | -1.05M | -1.05M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -41.51% | -17.34% | -79.96% | -6.22% | 31.15% | 22.88% | 27.34% | 20.18% | -53.20% | 12.93% | 39.75% | 52.64% | 16.68% | 11.91% | 13.69% | 22.57% | 6.09% | 9.92% | -62.95% | -62.95% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 484.22K | 1.10M | 2.43M | 2.94M | 7.29M | 15.30M | 6.69M | 7.14M | 9.98M | 8.53M | 8.18M | 3.93M | 2.59M | 2.61M | 487.30K | 362.29K | 338.33K | 155.71K | 175.82K | 597.55K | 647.78K | 419.88K | 103.26K | 103.26K |
| General & Administrative | 0.00 | 0.00 | 89.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.60M | 26.52M | 15.32M | 9.86M | 736.02K | 461.05K | 2.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 357.74K | 18.06K | 18.06K |
| Selling & Marketing | 0.00 | 0.00 | -19.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.45M | 2.24M | 2.41M | 2.10M | 0.00 | 0.00 | 2.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.83K | 11.83K | 0.00 |
| SG&A | 46.42M | 75.81M | 81.62M | 62.16M | 15.29M | 15.30M | 15.75M | 13.75M | 23.63M | 32.00M | 18.15M | 11.96M | 736.02K | 461.05K | 4.52M | 2.65M | 2.65M | 0.00 | 0.00 | 1.17M | 1.01M | 369.57K | 18.06K | 18.06K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.25M | 730.97K | 1.05M | 599.87K | 532.19K | 944.48K | 777.08K | 707.85K | 33.57K | 23.79K | 5.77K | 0.00 |
| Operating Expenses | 46.91M | -92.30M | -122.78M | -53.99M | -30.42M | 2.48M | -6.34M | -15.99M | -20.84M | -24.77M | -29.26M | 15.90M | 4.57M | 3.80M | 5.61M | 3.54M | 1.28M | 932.80K | 883.67K | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
| Cost & Expenses | 102.00M | -20.71M | -42.71M | -22.57M | -13.59M | 23.81M | 25.06M | 2.08M | 2.25M | -7.80M | -13.63M | 25.01M | 18.79M | 14.42M | 14.51M | 9.42M | 7.18M | 4.55M | 3.59M | 1.80M | 1.68M | 795.22K | 121.32K | 121.32K |
| Interest Income | 1.45K | 7.12K | 38.33K | 106.63K | 184.73K | 176.14K | 0.00 | 78.47K | 122.76K | 12.82K | 145.69K | 124.58K | 22.88K | 43.27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 30.08K | 0.00 |
| Interest Expense | 2.20M | 1.54M | 916.09K | 411.58K | 340.87K | 1.04M | -2.49M | 1.07M | 696.38K | 0.00 | 156.56K | 381.81K | 397.89K | 645.42K | 1.07M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.08K | 0.00 |
| Depreciation & Amortization | 3.69M | 7.60M | 23.96M | 7.93M | 3.05M | 3.54M | 3.52M | 2.58M | 1.72M | 352.94K | 613.20K | 768.41K | 943.32K | 730.97K | 599.87K | 532.19K | 966.03K | 797.10K | 724.96K | 39.90K | 23.79K | -5.77K | -5.77K | 0.00 |
| EBITDA | -63.05M | -79.89M | -95.65M | -58.94M | -11.84M | -18.99M | -4.88M | -13.19M | -39.51M | -37.27M | -14.86M | -4.87M | -3.41M | -1.59M | -3.34M | -1.11M | -950.60K | 324.37K | -1.20M | -1.76M | -1.66M | -789.45K | -121.32K | -121.32K |
| EBITDA Ratio | -119.84% | -130.95% | -214.99% | -199.28% | -48.43% | -68.69% | -11.28% | -58.27% | -262.19% | -191.16% | -57.26% | -25.30% | -20.01% | -13.22% | -32.39% | -14.59% | -15.14% | 8.08% | -72.51% | -106.11% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -66.74M | -87.49M | -119.61M | -66.87M | -14.88M | -22.53M | -8.40M | -15.77M | -41.23M | -37.62M | -15.47M | -5.76M | -1.87M | -3.01M | -4.19M | -1.83M | -900.48K | -534.64K | -1.93M | -1.80M | -1.68M | -795.22K | -121.32K | -121.32K |
| Operating Income Ratio | -126.85% | -143.41% | -268.84% | -226.08% | -60.89% | -81.50% | -19.44% | -69.67% | -273.60% | -192.97% | -59.63% | -29.94% | -10.96% | -25.01% | -40.61% | -24.02% | -14.34% | -13.32% | -116.18% | -108.51% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -53.28M | -17.02M | -40.94M | 10.61M | -8.14M | 30.23M | 11.38M | 3.01M | 11.65M | 15.38M | -3.49M | 138.13K | 2.63M | 1.55M | 2.30M | -184.53K | 1.94M | -61.91K | -1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -120.02M | -105.55M | -160.55M | -56.26M | -23.02M | 7.70M | 2.98M | -12.76M | -29.58M | -22.24M | -18.96M | -5.63M | 760.09K | -1.46M | -1.89M | -2.01M | 115.69K | -596.54K | -1.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -228.11% | -173.01% | -360.85% | -190.22% | -94.19% | 27.85% | 6.91% | -56.37% | -196.27% | -114.06% | -73.08% | -29.22% | 4.46% | -12.12% | -18.31% | -26.45% | 1.84% | -14.86% | -119.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.31M | -11.82M | 4.37M | 4.60M | 170.01K | 1.64M | 2.17M | 1.93M | 245.09K | 0.00 | 1.00M | -1.01M | -2.25M | 645.42K | 620.39K | 678.09K | -95.65K | 873.96K | 603.31K | 628.25K | -12.48K | -18.54K | 5.77K | 121.32K |
| Net Income | -81.71M | -93.73M | -154.80M | -60.86M | -23.19M | 17.53M | 6.38M | -7.47M | -27.96M | -16.64M | -16.77M | -4.62M | 527.52K | -1.46M | -4.81M | -2.50M | -804.82K | -1.41M | -2.59M | -2.43M | -1.67M | -765.13K | -121.32K | -121.32K |
| Net Income Ratio | -155.30% | -153.64% | -347.93% | -205.77% | -94.88% | 63.41% | 14.77% | -33.01% | -185.54% | -85.35% | -64.64% | -24.00% | 3.09% | -12.12% | -46.62% | -32.95% | -12.82% | -35.08% | -156.24% | -146.35% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -138.09 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
| EPS Diluted | -276.70 | -777.15 | -1.79K | -947.05 | -408.20 | 309.27 | 114.62 | -140.00 | -525.08 | -383.03 | -434.22 | -3.35 | -0.36 | -1.35 | -4.54 | -2.47 | -0.91 | -1.94 | -4.15 | -5.43 | -3.95 | -2.65 | -0.60 | -0.60 |
| Weighted Avg Shares Out | 295.31K | 120.61K | 86.54K | 64.27K | 56.81K | 56.14K | 55.68K | 53.36K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
| Weighted Avg Shares Out (Dil) | 295.31K | 120.61K | 86.63K | 64.27K | 56.81K | 56.69K | 55.82K | 54.10K | 53.25K | 43.44K | 38.62K | 1.38M | 1.16M | 1.08M | 1.06M | 1.01M | 879.74K | 727.23K | 625.29K | 447.34K | 421.95K | 288.57K | 201.14K | 201.14K |
Neptune Extends Maturity of Secured Promissory Note for Sprout Foods with Morgan Stanley
Maturity of $13 million Secured Promissory Note has been Extended to December 31, 2024 LAVAL, QC , April 27, 2023 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable...
Top Canadian Cannabis Stocks With Double Digit Percentage Gains In April
Are These Canadian Pot Stocks Going To See More Upside In May? The post Top Canadian Cannabis Stocks With Double Digit Percentage Gains In April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Best Canadian Marijuana Stocks To Buy? 2 For April 2023
Are These Canadian Pot Stocks On Your List For April? The post Best Canadian Marijuana Stocks To Buy? 2 For April 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Neptune Wellness Solutions Inc. (NEPT) Q3 2023 Earnings Call Transcript
Neptune Wellness Solutions Inc. (NASDAQ:NEPT ) Q3 2023 Results Conference Call March 30, 2023 5:00 PM ET Company Participants Valter Pinto - Managing Director, KCSA Michael Cammarata - President and Chief Executive Officer Raymond Silcock - Chief Financial Officer Conference...
3 Marijuana Stocks To Watch Before The Close
Ready To Invest In Cannabis? 3 Marijuana Stocks To Watch The post 3 Marijuana Stocks To Watch Before The Close appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Neptune Reports Fiscal Third Quarter Ended December 31, 2022 Financial Results
YTD net sales $40.5 million, up 8.6% from prior year Q3 net sales $12.2 million, down $2.5 million from last year, $3.5 million of decrease attributable to sale of cannabis business In Q3 Sprout outperformed Organic Shelf Stable Baby Food...
Neptune to Report Fiscal Third Quarter 2023 Financial Results on March 30, 2023
Company to host a conference call at 5:00 p.m. (Eastern Time) LAVAL, QC , March 30, 2023 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle...
Neptune to Report Fiscal Third Quarter 2023 Financial Results on March 30, 2023
Company to host a conference call at 5:00 p.m. (Eastern Time) LAVAL, QC, March 30, 2023 /PRNewswire/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands,...
Top Marijuana Penny Stocks For April 2023
Top Pot Stocks To Watch For April The post Top Marijuana Penny Stocks For April 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week
Canadian Pot Stocks For Watchlist This Week The post Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Source: https://incomestatements.info
Category: Stock Reports